Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person14
REPLIGEN CORP
Company
REGIS CORP
Company
NEOGEN CORP
Company
RLI CORP
Company
RTX Corp
Company
Redwire Corp
Company
RENASANT CORP
Company
AMREP CORP.
Company
Repay Holdings Corp
Company
REGENCY CENTERS CORP
Company
AMEREN CORP
Company
GENTEX CORP
Company
ROGERS CORP
Company
Roblox Corp
Company
Primary record12
REPLIGEN CORP filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. On November 6, 2026, in connection with the consummation of previously announced private exchange and subscription transactions, Repligen Corporation (the “Company”)
REPLIGEN CORP filed 8-K
Item 3.02 Unregistered Sales of Equity Securities. The Information set forth under Item 8.01 of this Current Report on Form 8-K is incorporated herein by reference. Item 8.01 Other Events. On October 30, 2026, Repligen C
REPLIGEN CORP filed 8-K
Item 2.02 Results of Operations and Financial Condition. On October 27, 2026, Repligen Corporation announced its financial results for the third quarter ended September 30, 2026. The full text of the press release issued
REPLIGEN CORP filed 4
SEC form 4 filed by REPLIGEN CORP (CIK 730272) on 2026-10-08.
FMR LLC filed SCHEDULE 13G/A
0000315066-26-002329.txt : 20261007 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0000315066-26-000516 0000315066 XXXXXXXX LIVE 1 COMMON STOCK 09/30/2026 0000730272 REPLIGEN CORP 759916109 41 SEYON STREET BUILDIN
REPLIGEN CORP filed 8-K
Item 2.01. Completion of Acquisition or Disposition of Assets. The information set forth in the Explanatory Note of this Current Report on Form 8-K is incorporated by reference into this Item 2.01. At the effective time
REPLIGEN CORP filed 4
SEC form 4 filed by REPLIGEN CORP (CIK 730272) on 2026-09-28.
REPLIGEN CORP filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 10, 2026, Karen A. Dawes notified Repligen Corpora
REPLIGEN CORP filed 8-K
Item 8.01. Other Events. As previously disclosed, on July 21, 2026, Repligen Corporation, a Delaware corporation (“Repligen”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Bravo Merger Sub I
REPLIGEN CORP filed 4
SEC form 4 filed by REPLIGEN CORP (CIK 730272) on 2026-09-02.
Azenta, Inc. filed 8-K
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Resignation of President and Chief Executive Officer On August
PRICE T ROWE ASSOCIATES INC /MD/ filed SCHEDULE 13G/A
0000080255-26-000536.txt : 20260814 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0000080255-22-001963 0000080255 XXXXXXXX LIVE 8 COMMON STOCK 06/30/2026 0000730272 REPLIGEN CORP 759916109 41 SEYON STREET BUILDIN